Publication:
Isoniazid- and rifampicin-induced thrombocytopenia

Thumbnail Image

Organizational Units

Program

Authors

Authors

Yakar, Fatih
Yildiz, Namsan
Yakar, Aysun
Kilicaslan, Zeki

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Treatment of tuberculosis has many side effects. Thrombocytopenia is a serious side effect of such treatment and occurs mostly due to rifampicin (RIF). There are very few reported cases of thrombocytopenia due to isoniazid (INH). An 18-year-old female patient was diagnosed with smear-positive pulmonary tuberculosis. A four-drug regimen [INH, RIF, ethambutol (EMB), and pyrazinamide (PZA)] was given. After the development of thrombocytopenia, the drug treatment was stopped, and a thrombocyte suspension was given until a normal thrombocyte count was obtained. After several start-stop trials, first INH and then RIF were identified as the possible causes of thrombocytopenia and were removed from the regimen. The patient was treated with EMB, streptomycin, PZA, and moxifloxacin with no further development of thrombocytopenia. The current case shows that antituberculosis drugs other than RIF and PZA may be responsible for the development of thrombocytopenia.

Description

Source:

Keywords:

Citation

Yakar F., Yildiz N., Yakar A., Kilicaslan Z., -Isoniazid- and rifampicin-induced thrombocytopenia-, MULTIDISCIPLINARY RESPIRATORY MEDICINE, cilt.8, 2013

Endorsement

Review

Supplemented By

Referenced By

0

Views

10

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal